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In previous research, progesterone has been supplemented using various techniques, at 
differing time points during peri-insemination in cattle, with conflicting results. Little
research has been conducted on the effects of intravaginal delivery of supplemental 
progesterone following transfer of embryos produced in vitro, and no research was found
to investigate this method exclusively in the period post-transfer.  Pregnancy rates 
following the transfer of embryos produced in vitro are considered less than ideal, 
especially if these embryos have been cryopreserved.  Embryos produced in vitro are less 
equipped to handle the freezing process due to alternative ultrastructural differences, and 
display lesser developmental potential in the post-transfer environment compared to 
embryos derived in vivo.  The objective of this study was to evaluate the effect of a CIDR 
insert following the transfer of IVP embryos on pregnancy rates and circulating
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In mammals, the ovary is the primary site of synthesis and secretion of
progesterone and estrogen, which mediate several actions throughout the estrous cycle 
(Graham and Clark, 1997).  A continuous supply of cholesterol is imminent for 
steroidogenesis. Three potential sources are de novo synthesis, hydrolysis of stored 
cholesterol esters, or exogenesis high- and low- density lipoproteins, with the latter being
the primary source for steroid production in the corpus luteum (CL), a transient endocrine
organ formed in the ovary following ovulation (Stocco et al., 2007).  Progesterone is the
pro-gestational hormone that is primarily synthesized by the CL, but can also be
produced by the placenta and adrenal glands.  Progesterone acts on various target tissues, 
but the principal tissues include: the hypothalamo-pituitary axis, reproductive tract, and 
mammary gland (Niswender, 2002). In the uterus, progesterone prepares the
endometrium for the initiation and maintenance of pregnancy by inducing cell
differentiation (Cummings and Yochim, 1984), glandular secretions and alterations in 
protein secretions of endometrial cells (Maslar et al., 1986) while suppressing
contractility of the myometrium (Parkington, 1983).  The initial, rate-limiting step of
steroidogenesis is the transport of cholesterol from the cytoplasm into the inner




   
   
  
   
    










   
al., 2007).  Here, cholesterol is converted to pregnenolone by mitochondrial cytochrome
p450 side chain cleavage (P450scc; Jefcoate et al., 1992) then to progesterone via and 3-
beta hydroxysteroid dehydrogenase (3β-HSDII) in the smooth endoplasmic reticulum
(Labrie et al., 1992). 
The CL is a heterogeneous gland comprised of large steroidogenic luteal cells and 
small steroidogenic luteal cells, with large luteal cells producing 2- to 40- fold more
progesterone than small luteal cells in ruminants (Stocco et al., 2007). While both large
and small luteal cells contain receptors for lutenizing hormone (LH), only small luteal 
cells respond to LH, or cyclic adenosine monophosphate (cAMP) with a 5- to 15-fold 
increase in secretion of progesterone (Niswender, 2002).  When LH binds to its receptors 
on small luteal cells, protein kinase A (PKA) second messenger pathway is activated, 
stimulating secretions of progesterone (Niswender, 2002).  In contrast, large luteal cells 
contain prostaglandin F2alpha (PGF2α) receptors; when PGF2α binds to activate protein 
kinase C (PKC) and inhibit secretions of progesterone, and also increase concentrations 
of intracellular free calcium (Wiltbank et al., 1991) which promotes apoptosis and 
cellular degeneration (Niswender, 2002).  These small and large luteal cells are
derivatives of theca and granulosal cells, respectively.  
Chronic secretions of progesterone from the CL are mitigated via LH stimulation, 
and its control mRNA concentrations coding for enzymes and proteins required for
steroidogenesis (Juengel et al., 1995).  Every luteal cell has immediate contact with 
numerous capillaries, giving the CL one of the largest rates of blood flow of any tissue, 
and allowing for efficient outputs of progesterone (Stocco et al., 2007). In many species, 










   
 
  




    
    
 
1979), while transcortin, a corticosteroid binding globulin that typically binds cortisol
and corticosterone, accounts for 20% of transportation of progesterone in the bloodstream 
(Graham and Clarke, 1997).  The physiological actions of progesterone on target cells are
modulated through the binding to its nuclear receptors in one of two isoforms: A or B, or 
through non-genomic actions via progesterone receptor membrane component 1 
(PGRMC1) and its homolog (PGRMC2).  The nuclear receptor belongs to a family of 
ligand-activated nuclear transcription regulators, characterized as having a highly
conserved, DNA-binding domain, and a carboxy-terminal ligand-binding domain 
(Graham and Clarke, 1997).  The two isoforms differ only in length at the amino-
terminus, with progesterone receptor-A having 164 additional amino acids (Kastner et al., 
1990).  Both isoforms of the nuclear progesterone receptor originate from differential 
promoter usage in a single gene, and bind progestins and modulate transcription of target 
genes, such as lipoprotein lipase (LPL) and connective tissue growth factor (CTGF) via 
progestin response elements located in promoter regions of these genes (Kastner et al., 
1990; Graham and Clarke, 1997; Forde et al., 2010). Elevated progesterone was found to 
modify LPL expression in the bovine uterus (Forde et al., 2010). LPL codes for an 
enzyme involved in lipid metabolism and transport, specifically of triacylglyerols (TAGs)
that are thought to function as an energy source for the conceptus prior to glucose
availability at the blastocyst developmental stage (Fergusen and Leese, 2006).  CTGF
expression, involved in cell proliferation, migration and/or adhesion of conceptus 
trophectoderm during early pregnancy and likely associated with conceptus elongation, is
also upregulated in the presence of progesterone (Forde et al., 2010). All steroid 










   








messenger pathways and signal transducing pathways without transcriptional modulation 
of target genes, that can lead to extensive and sustained downstream consequences 
(Gellersen et al., 2009).  
Finidori-Lepicard et al., (1981) reported progesterone is responsible for signaling
the resumption of meiotic division of oocytes arrested in the G2 phase through means of 
adenylate cyclase inhibition and reduction of intracellular concentrations of cAMP.  The 
expression of progesterone receptors is found in an abundance of tissue types, and is 
controlled by estrogen and progesterone, which increases and decreases subsequent 
progesterone receptor expression in target tissues, respectively (Graham and Clarke, 
1997).  The postovulatory rise in circulating concentrations of progesterone negates 
proliferative activity and contractility, and induces remodeling of endometrial tissue
necessary for embryo growth and implantation (Dey et al., 2004; Gray et al., 2006). 
Myometrial contractions are reduced through increasing resting potentials and preventing
electrical coupling between myometrial cells (Parkington, 1983), decreasing the uptake of 
extracellular calcium necessary for contraction of myometrial cells (Batra, 1986), and 
downregulating genes encoding voltage-dependent calcium channels (Tezuka et al., 
1995). Rueda et al., (2000) reported a steroid- ligand relationship between lesser 
concentrations of progesterone and increased apoptosis in bovine luteal cells.  
Progesterone mitigates prostaglandin production in the uterine environment during
gestation by inhibiting the expression of cyclooxygenase (COX-2) coupled with 
upregulating the prostaglandin catabolizing enzyme, 15-prostaglandin dehydrogenase
(Graham and Clarke, 1997).  Progesterone is an essential hormone in the establishment 




   
  















estrus decrease early embryo survivability (Mann and Lamming, 2001).  Concentrations 
of progesterone and their effects on embryonic development and pregnancy outcome
have been thoroughly investigated (Mann and Lamming, 2001; Starbuck et al., 2006; 
Forde et al., 2011).  Forde et al., (2011) reported that low concentrations of progesterone
have deleterious effects on uterine histotroph and subsequent conceptus elongation, 
supporting previous research that indicates P4 regulates endometrial secretions through 
altering gene expression in the uterine endometrium (Bauersachs et al., 2006).  Follicular 
development is also regulated by concentrations of progesterone and the negative – 
feedback control exerted on the frequency of pulsatile gonadotropin- releasing hormone
(GnRH) and subsequent LH secretions (Kinder et al., 1996). In lactating dairy cows, the 
metabolism of estrogen and progesterone is 2.8 times higher compared with non-lactating
animals, suggesting that milk production influences circulating progesterone
concentrations (Sangsritavong et al., 2002) through increased liver blood flow and steroid 
metabolism (Wiltbank et al., 2006).  
Supplemental progesterone
Exogenous progesterone has been supplemented in numerous studies through 
mechanisms such as: daily injections of progesterone (Butcher et al., 1992; Garrett et al., 
1988), and vaginally via insertion of a controlled internal drug releasing (CIDR) device
(Van Cleeff et al., 1996; Purcell et al., 2005; Larson et al., 2007; Chebel et al., 2010; van 
Werven et al., 2013) or progesterone-releasing device (PRID; Stevenson and Mee, 1991; 
Walsh et al., 2007; van Werven et al., 2013; O’Hara et al., 2014). Endogenous 














   
  






supplementation of human chorionic gonadotropin (hCG) to induce the formation of 
accessory CL (Schmidt et al., 1996; Kerbler et al., 1997; Santos et al., 2001; Lonergan, 
2011; Torres et al., 2013), Yan et al., (2016) reviewed 37 studies and found that there was 
no difference in pregnancy rate odds ratio due to the source of exogenous progesterone, 
or the administration of progesterone versus progestogens.  Supplementation of 
progesterone has produced varying effects on pregnancy rates (Mann and Lamming, 
2001). The volume of literature reporting positive effects of supplemental progesterone
on pregnancy (Larson et al., 2007; Stevenson et al., 2007; Forro et al., 2012; Colazo et 
al., 2013) is ambiguous with studies concluding no significant differences (Villarroel et 
al., 2004; Arndt et al., 2009; Scott et al., 2009; Monteiro et al., 2014; 2015). However, 
there are a handful of studies that found supplemental progesterone to have deleterious 
effects on pregnancy rates (VanCleeff et al., 1996; Parr et al., 2014; Monteiro et al., 
2015).  
Supplemental progesterone has been administered pre- and post- timed artificial 
insemination (TAI) (Arndt et al., 2009; Colazo et al., 2013) and pre-transfer of in vivo
derived embryos (Nishigai et al., 2002).  One study has previously investigated the
effects of a CIDR device on pregnancy rates of IVP embryos transferred to lactating dairy
cows over a 14-day period (from 4 days prior to transfer through 10 days after transfer)
(Monteiro et al., 2015), but literature is lacking in post- in vitro produced embryo 
transfer.  Monteiro et al., (2015) concluded supplemental progesterone via CIDR insert 
from day -4 until day 10 post-transfer of IVP embryos decreased pregnancy rates 
compared to recipients receiving a CIDR for only 4 days (inserted 4 days prior to transfer 




   
    










(15.2% vs. 21.3% vs. 39.7%, respectively).  The timing of supplementation and the initial 
herd pregnancy rates are important factors affecting the efficacy of supplementing
progesterone to cattle (Mann et al., 2006; Mann and Lamming, 1991).  Supplemental 
progesterone during the peri-insemination period increased trophoblastic length and 
increased uterine concentrations of interferon-tau by 4- fold and 6- fold, respectively
(Mann et al., 2006).  Garrett et al. (1988a) recorded increased endometrial growth factors 
and protein secretions following supplementation of progesterone, which can be involved 
in early embryonic development and survival.  Mann and Lamming (2001), noted an 
overall increase of pregnancy rates by 10.3% following review of several exogenous 
progesterone studies, indicating the early luteal phase to be the optimal time of
supplementation.  Supplemental progesterone accelerates normal, temporal modifications 
in gene expression of the endometrium, particularly those associated with uterine 
histotroph composition (Lonergan et al., 2016), which could facilitate higher rates of 
conceptus growth and development (Garrett et al., 1988a).  Administration of
progesterone enhances the secretion of interferon-tau by the conceptus (Mann et al., 
2006), embryonic growth rate (Carter et al., 2010), and overall embryo survivability
(Inskeep et al., 2004).  Carter et al., (2010) recorded altered gene expression of 191 genes 
(114- down regulated and 71 up-regulated) exhibiting greater than 1.5-fold expression in 
embryos cultured from oviducts of heifers receiving supplemental progesterone via PRID 
compared to heifers without supplemental progesterone.  Following intramuscular 
injections of progesterone during the first 4 days of pregnancy, Garrett et al., (1988b)




   
  
  




   






consistent with earlier maturation of the uterine environment and advanced release of 
PGF2α from the endometrium (Garrett et al., 1987).
The administration of RU486, a progesterone receptor antagonist, negated the 
effect of supplemental progesterone on conceptus growth and elongation (Clemente et al., 
2009).  Insertion of a PRID into heifers from days 3 to 7 after embryo transfer increased 
circulating concentrations of progesterone 4- to 5- fold and increased conceptus 
elongation when recovered on day 14 of gestation (Clemente et al., 2009). However, 
Robinson et al., (1989) found that insertion of a PRID into dairy cattle from day 10 to day
17 following insemination increased pregnancy rates, but suppressed endogenous 
production of progesterone.  Arndt et al., (2009) reported no difference in pregnancy rates 
of dairy cows that received a CIDR device from d 4 to 18 post-insemination compared to 
cows that received no exogenous progesterone.  Carter et al., (2008) concluded that 
insertion of a PRID on day 3 of the estrous cycle increased concentrations of 
progesterone on subsequent days and was associated with greater embryonic size on days 
13 and 16 of gestation, but did not alter stage of embryonic development on day 5 and 7 
of pregnancy. Supplemental progesterone during culture of in vitro produced embryos 
resulted in no advantageous effects on embryo development (Clemente et al., 2009;
Larson et al., 2011).   
Intravaginal CIDR devices are primarily implemented to suppress ovulation and 
synchronize estrus, and the effects on estrus synchrony were similar to the PRID while
providing easier application, better retention rates, and reduced incidence of vaginitis in 
virgin heifers (Broadbent et al., 1993).  Intravaginal CIDR devices are comprised of a



















insertion process, and expand to the original ‘T’ shape and apply pressure to the vaginal 
canal to remain in place.  The first CIDR-B inserts contained 1.9 grams of micronized 
progesterone and were initially formulated to deliver progesterone over a 12-day period 
(Rathbone et al., 2002), and while efficient at synchronizing estrus and suppressing
ovulation, the subsequent fertility was hindered due to an increase in the duration of
dominance of follicles (Mihm et al., 1999).  Currently, a commercially available CIDR 
device contains 1.38 grams of progesterone (Rathbone et al., 2002). When a CIDR is 
administered to ovariectomized Holstein cows, serum concentrations of progesterone
begin increasing an hour after insertion, and decline just as rapidly once the device is 
removed (Rathbone et al., 2002). 
In vitro embryo production
Assisted reproductive technologies such as in vitro production (IVP) of embryos 
have been associated with increased pregnancy failure when compared to artificial 
insemination and conventional embryo transfer techniques. This failure of pregnancy to 
establish may be due to a reduction in post-transfer, developmental competence of 
embryos produced in vitro compared to those produced in vivo (Hasler et al., 1995).  
Oocytes are obtained from donor females via transvaginal aspiration of follicular fluid 
through an ultrasound-guided needle (Galli et al., 2004).  Ovum pickup (OPU)
procedures can be performed every 12 to 18 days, and through the first 100 days of 
gestation (Phillips and Jahnke, 2016).  Oocytes recovered on farm, or in a clinic are
matured and fertilized in a laboratory before being frozen, or fresh-transferred into 














    
 
 
    
 
day 0 in IVP embryos is the day of in vitro fertilization (IVF) while day 0 in embryos 
produced through superovulation and AI is deemed as the day of estrus of the donor
(Hasler, 2014).  Any recipients to be asynchronous with donor (6 days vs. 7 or 8 days 
post-estrus) at time of transfer of IVP embryos previously resulted in a reduction of
pregnancy rates by 10 to 16% (Hasler, 1998; 2014).  As of 2009, the vast majority of all
beef and dairy embryos (99% and 94%, respectively) are frozen in a direct transfer 
cryopreservation system in 0.25 mL straws containing ethylene glycol as the
cryoprotectant (Hasler, 2014).  Pontes et al., (2010) reported a higher yield of oocytes 
from Bos indicus donors than Bos taurus breeds, and of all oocytes recovered on average
(11.4 ± 3.9) from Holstein donors following OPU procedures, 69.9% (8.0 ± 2.7) were
viable and 18.7% (2.1) yielded embryos without the use of exogenous hormones.  
However, despite breed effects on donor oocyte characteristics, pregnancy rates were
similar between either source of oocytes (Pontes et a., 2010).  On average, 9 days of in 
vitro culture are required from the time oocytes are aspirated from donors until resultant 
embryos may be vitrified or transferred into recipient females (Blondin, 2017).  Sexed 
semen is often used in conjunction with IVP to predetermine embryo sex at conception, 
and optimize production and profitability (Morotti et al., 2014).  In 2016, almost 5 
million straws of sexed semen were processed in the United States, 90% of which were
from dairy sires (Moore and Hasler, 2017).  Xu et al., (2006) found that the in vitro
fertility of bulls is affected by the sorting process and can have negative effects on 
blastocyst production.
The percentage of bovine oocytes that reach the blastocyst development stage

















matured in vivo and subjected to IVF have a blastocyst rate of 60% (Rizos et al., 2002).  
Furthermore, Rizos et al., (2002) obtained in vivo matured oocytes via donor estrus 
synchronization, ablation of the dominant follicle on day 8 of the estrous cycle, twice
daily injections of follicle stimulating hormone (FSH) from day 10 to 14, and follicular 
aspiration of follicles larger than 6 mm on day 14.  The ablation of a dominant follicle
can be achieved through various tactics such as: ultrasound-guided aspiration, estradiol-
17β, and gonadotropin-releasing hormone (Bó and Mapletoft, 2014).  Shaw and Good, 
(2000) compared recovery rates of oocytes and quality of resultant embryos produced 
from donors that underwent dominant follicle ablation to non-ablated donors.  They
reported more oocytes were recovered from donors that had the dominant follicle
removed, but the amount of high quality embryos did not differ between groups, 
indicating the higher volume of oocytes resulted in primarily nontransferable embryos 
(Shaw and Good, 2000).  Factors influencing the developmental potential, yield, and 
quality of IVP embryos can include: initial oocyte source, quality, and maturation and 
fertilization conditions, sperm preparation techniques, and embryo culture environments.  
Cumulus-oocyte complex morphology, the number of cumulus cell layers, oocyte
coloration and diameter, the amount of periviteline space, and zona pellucida thickness 
and organization are all morphological factors that influence oocyte quality and future
developmental capacity (Blondin and Sirand, 1995; Fair, 2003; Gabrielsen et al., 2001).  
The alteration of in vitro media culture from a one-step system utilizing serum 
supplementation with, or without cell co-culture to sequential defined, or semi- defined 


















media culture utilized in commercial IVF systems can account for differences in quantity, 
cryosensitivity, and pregnancy rates of high- quality embryos produced (Blondin, 2017).  
A blastocyst consists of an inner cell mass (ICM) and blastocoele enclosed in a 
single layer of trophectoderm.  While Hoelker et al., (2014) reviewed the relationship 
between insemination and time of first cleavage to affect the likelihood of embryos to 
reach the blastocyst developmental stage, Kubisch et al., (1998) concluded that the timing
of cleavage does not accurately predict the timing of blastocyst development, or the
incidence of hatching.  Around day 8 of pregnancy, the blastocyst will hatch from the
zona pellucida and proceed to form an ovoid, then tubular, and filamentous form that is 
known from then on as the conceptus (Spencer et al., 2016).  In the ruminant conceptus, 
the primary secretory protein around the time of attachment is interferon-tau (Roberts et 
al., 1992); it can be detected in the trophoblastic cells from day 12 until day 25 (Farin et 
al., 1990).  Kubisch et al., (1998) observed less production of interferon-tau by IVP 
embryos that achieved the blastocyst developmental stage earlier (day 7 or 8) than later 
(day 9 or 10), but previous research has indicated earlier developing blastocysts yield 
higher pregnancy rates post-transfer into recipients (Hasler et al., 1995).  Kubisch et al., 
(1998) also found that the longer an embryo took to develop into a blastocyst, the more
unlikely that embryo was to hatch.  
Post-transfer, embryos produced in vitro can exhibit normal growth and 
development, end in abortion, or develop fetal and placental defects (Farin et al., 2006).  
Kruip and den Daas, (1997) reported higher rates of abortion, stillbirths (14.6% vs. 
7.8%), perinatal calf mortality (26.8% vs. 9.5%), and incidence of hydroallantois (5.2%





   







   
   
 
   
  






compared to AI, or in vivo embryo-derived calves, IVP calves were also heavier at birth; 
an observation that is only partially explained by a longer gestational length
(Wagtendonk-de Leeuw et al., 2000).  Embryos produced in vitro have yielded varying
pregnancy rates, ranging from 27.7% (Block et al., 2010) to 39.7% (Monteiro et al., 
2015) in recent studies, and as high as 45% (Thompson et al., 1989) previously.  
Implications and conclusions
In vitro production of bovine embryos offers various advantages to milk and beef 
production compared to artificial insemination and in vivo embryo breeding schemes 
(Blondin, 2017).  However, this process results in ultrastructural, metabolic, and genetic
alterations not observed in embryos derived in vivo (Kruip and Daas, 1997; Khurana and 
Niemann, 2000: Lazzari et al., 2002). These alterations can lead to reduced abilities of
embryos to establish and maintain a pregnancy. 
Progesterone is the pro-gestational hormone responsible for optimizing the uterine
environment for early embryonic development and attachment through reducing
myometrial contractions and increasing glandular secretions from the endometrium
(Forde et al., 2010). When progesterone has been supplemented exogenously in previous
studies, conceptus length has increased to various degrees around the time of maternal 
recognition (between d 15 and 17; Carter et al., 2010; O’Hara et al., 2014).  These larger 
concepti secrete larger amounts of the anti-luteolytic protein interferon-tau (IFN-τ), 
which suppresses pulsatile prostaglandin F2-alpha and disallows the CL to undergo 
luteolysis (Cheng et al., 2007). It is thought that supplemental progesterone in the form 
of a CIDR insert could negate developmental incompetence of bovine embryos produced 
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CHAPTER II
THE EFFECTS OF SUPPLEMENTAL PROGESTERONE VIA A CIDR INSERT ON
PREGNANCY RATES IN DAIRY HEIFER RECIPIENTS OF IVP EMBRYOS
Introduction
The production of embryos in vitro has exhibited exponential growth since the 
1990s, and since 2013 alone (Blondin, 2017). In 2014, 500,000 IVP embryos were
produced and accounted for almost 50% of global embryo production (Blondin, 2017), 
but pregnancy rates following transfer of IVP embryos are still less than ideal (Block et 
al., 2010; de Souza et al., 2017). Early embryonic loss accounts for 75 to 80% of 
pregnancy loss in natural bovine pregnancies (Sreenan and Diskin, 1983), and 
approximately 40% of embryonic loss is estimated to occur between d 8 and 16 of
pregnancy (Lonergan, 2011).  
Factors contributing to such a loss may include poor embryo quality (Lussier et 
al., 1987), inefficient cross-talk between endometrial cells and the conceptus (Ulbrich et 
al., 2010), as well as asynchrony between donor and recipient females (Ferraz et al., 
2016). In early gestation, endometrial secretions of growth factors, nutrients, steroids, 
ions, enzymes and immunosuppressive agents that are imperative for embryonic 
development are heavily influenced by progesterone (Graham and Clark, 1997).












   
   




concentrations of progesterone and reduced embryo development coupled with a delayed 
post-ovulatory increase in plasma progesterone and reduced concentrations of 
progesterone. Lesser circulating concentrations of progesterone between days 3 to 8 
post-ovulation have yielded smaller day 16 embryos, which can negatively affect 
production of interferon-tau and interfere with successful maternal recognition of 
pregnancy (Mann and Lamming, 2001).  Conversely, increased concentrations of 
progesterone in the first week post-ovulation increases production of interferon-tau 
(Mann and Lamming, 1999), enhances endometrial gene expression that improve uterine 
histotroph (Forde et al., 2009), and accelerates conceptus growth parameters (Garrett et 
al., 1988).  Progesterone has been exogenously supplemented in numerous studies 
through various methods: daily injections of progesterone (Garrett et al., 2008), and 
vaginally via insertion of a controlled internal drug releasing (CIDR) device (Van Cleeff
et al., 1996) or progesterone-releasing device (PRID; O’Hara et al., 2014). Endogenous 
concentrations of progesterone can also be increased following supplementation with 
hCG to induce formations of accessory CL (Kerbler et al., 1997; Wallace et al., (2011).
Pregnancy rates after transfer of in vivo generated embryos (ET) have also 
increased in recipient females administered 1,000 IU human chorionic gonadotropin 
(hCG) at time of transfer compared to control animals (Wallace et al., 2011).  Compared 
to their in vivo counterparts, IVP embryos are less cryotolerant and exhibit lower 
developmental competence post-transfer (Hasler et al., 1995).  Monteiro et al., (2015) has 
previously studied the effect of supplemental progesterone, beginning before transfer and 
continuing through 10 days after, on IVP embryo transfer pregnancy rates via a CIDR 




   
     
    
  
   
 














recipients.  However, the administration of CIDR devices in recipient animals, after the
transfer of IVP embryos, to rescue high-risk embryos is a field of reproductive
physiology that warrants further investigation. The objective of this study was to 
determine whether supplemental progesterone via a CIDR immediately after embryo 
transfer (d 7) through d 19 would increase conception rates in dairy heifer recipients and 
influence circulating concentrations of progesterone.  We hypothesized that supplemental 
progesterone after embryo transfer would increase pregnancy rates.
Materials and methods
Animals
Nulliparous Holstein heifers (n = 452; 479 ± 33 d of age) were used in this embryo 
transfer study.  Only 175 of the 452 heifers in this study were assessed and scored for 
body condition by two trained individuals as previously described (1 to 5; Wildman et al., 
1982; Edmonson et al., 1989).  Heifers were housed on pasture and supplemented with a 
concentrate to meet or exceed nutritional requirements.  
Embryo transfer
Heifers were grouped into 9 transfer groups based on age of heifer as well as lack of 
previous conception. Each group had at least 25 but no more than 84 heifers. The first 
transfer group received embryos in early December, 2016 and the last group in the study
received embryos in April, 2017.  For heifers in each group, ovulation was synchronized 
via a Co-Synch + CIDR protocol (Lamb et al., 2001). Estrotect patches (Western Point, 








    
 





   





Grove Village, IL) were used as estrus detection aids in addition to daily, visual 
inspection for estrous behavior.  Heifers observed in estrus (designated as d 0) were
evaluated on the day of transfer (6 to 8 d after estrus; 7.15 ± 0.48 d average) for 
suitability for embryo transfer.  At the time of transfer, transrectal ultrasonography was 
used to examine ovarian structures by a single, experienced technician using a 7.5 MHz
transducing probe (Ibex Pro; E.I. Medical Imaging, Loveland,CO).  Animals with cystic
structures, CL smaller than 10 mm in diameter, or anatomical tract abnormalities (n = 36) 
did not receive an embryo and were excluded from the study.  Cavernous CL as well as 
location (right or left ovary) of CL were recorded. Before transfer, all heifers received 
epidural anesthesia (3 mL of 2% Lidocaine, MWI Animal Health; Boise, ID).  Suitable 
recipients received frozen-thawed, IVF-produced (TransOva Genetics, Boonsboro, MD)
embryos according to the standard embryo transfer technique from the International 
Embryo Transfer Society (IETS; Savoy, IL) that were transferred into the uterine horn
ipsilateral to the CL by the same experienced technician. Embryos were products of 48 
different matings of 35 Holstein donor females and sex-sorted semen from 12 Holstein 
bulls and allocated equally among treatments.  Prior to freezing, all embryos were
assigned a developmental stage and quality grade in accordance with the IETS standards.  
Developmental stage codes utilized in this study were: 4 = morula, 5 = early blastocyst, 6 
= blastocyst, and 7 = expanded blastocyst.  Quality grades were: 1 = (excellent/good) 
symmetrical and spherical embryo mass with individual blastomeres that are uniform in 
size, color, and density with at least 85% of the embryonic cells are an intact, viable, and 
cohesive mass, and 2 = (fair) moderate irregularities present in the shape of the 

















   
    
 
least 50% of embryonic cells being an intact, viable, and cohesive mass. Heifers suitable 
to receive an embryo were randomly assigned to 1 of 2 treatments at the time of transfer: 
1) control (n = 212) with no further treatment, or 2) to receive an intravaginal controlled 
internal drug release device containing 1.38 g of progesterone for 12 d (n = 228; Eazi 
Breed CIDR; Zoetis Animal Health, Parsippany, NJ).    
Blood collection and analysis
Blood samples were collected from a subset of heifers (all heifers from 3 transfer groups;
n = 186) via coccygeal venipuncture into 10 mL evacuated tubes (Vacutainer; Becton, 
Dickinson and Company; Franklin Lakes, NJ). Blood was collected at d 7 (ET) and d 19 
(CIDR removal).  After collection, blood was refrigerated at 4°C for 24 hr before being
centrifuged at 4°C at 1,500 x g for 15 min.  Serum was removed and stored at -20°C until 
analysis. Samples were later analyzed for concentrations of progesterone via 
immunoassay (Immulite 1000, Siemens, Malvern, PA) according to manufacturer's 
instructions.
Pregnancy diagnosis
Pregnancy was diagnosed via serum assay for pregnancy-specific protein B (PSPB; Bio 
Tracking, Inc. Moscow, ID) and confirmed with real-time ultrasonography or rectal 
palpation by an experienced technician.  Pregnancy was diagnosed between d 36 and 57
of gestation (hereafter referred to as d 30) depending on transfer group and confirmed a





   
    
  
   
    




   
   







Some independent variables were grouped for analysis and care was taken so they were
evenly distributed among both treatment groups.  Heifers were separated into 5 different 
age groups: 1 (403-449 days; n = 76), 2 (450-495 days; n = 248), 3 (496-541 days; n = 
80), 4 (542-587 days; n = 16), and 5 (588-631; n = 5).  Concentrations of progesterone on 
d 7 and d 19 were also separated into 11 different groups: 1 (0-0.5 ng/mL; n = 1); 2 (0.5-
1.5 ng/mL; n = 3), 3 (1.5-2.5 ng/mL; n = 24), 4 (2.5-3.5 ng/mL; n = 47), 5 (3.5-4.5 
ng/mL; n = 39), 6 (4.5-5.5 ng/mL; n = 33), 7 (5.5-6.5 ng/mL; n = 13), 8 (6.5-7.5 ng/mL; n
= 5), 9 (7.5-8.5 ng/mL; n = 4), 10 (8.5-9.5; n = 2), and 11 (> 9.5 ng/mL; n = 2). 
Pregnancy rate was analyzed using the GLIMMIX procedure of SAS (9.4; SAS Institute, 
Inc., Cary, NC)  and the initial model included treatment, age of heifer, BCS, donor-
recipient synchrony, sire, date of transfer, embryo quality grade and developmental stage, 
ovulatory side, and serum concentrations of progesterone. Terms with the greatest P-
value were removed individually from the model in a backwards, stepwise manner to 
derive the final model for each dependent variable. Two way interactions of all
independent variables in the final models were included when 𝑃 < 0.10. Observations 
from 440 heifers were included in the final model for pregnancy status at d 30 and d 60.  
The final model for pregnancy rate at d 30 included the effects of treatment, group, sire, 
and the interaction of treatment × sire. The final model for pregnancy rate at d 60 
included the effects of treatment, sire, and the interaction of treatment × sire.  The GLM 
procedure of SAS (9.4) was used to analyze concentrations of progesterone   and the 
initial model included: treatment, age of heifer, BCS, donor- recipient synchrony, sire, 









   
   
  
 





    
   
 
   
pregnancy status.  Observations from 175 heifers were included in the final model for 
concentrations of progesterone at d 7. Observations from 172 heifers were included in 
the final model for concentrations of progesterone at d 19.  The final model for
concentrations of progesterone at d 7 included date of transfer, donor-recipient 
synchrony, and the respective two-way interaction.  The final model for concentrations of 
progesterone at d 19 included the effects of treatment, pregnancy status at d 30, date of
transfer, and the interactions of d 30 pregnancy status × date of transfer and d 30 
pregnancy status × treatment.  Each mating(batch) was distributed equally amongst 
treatment groups, so donor and batch were excluded from final analyses. In all cases, 
statistical significance was declared at 𝑃 ≤ 0.05. 
Results
Pregnancy rates
Of all 452 dairy heifer recipients, overall pregnancy rates obtained were 27.5 and 23.3%
at d 30 and 60 of gestation, respectively (figure 1). Pregnancy rates were similar between
treatments at either pregnancy diagnosis (d 30), or confirmation (d 60).  For initial 
pregnancy diagnosis, there was a significant effect of sire, group (Table 1) and 
treatment×sire on pregnancy rates, while sire and the interaction of treatment×sire
affected pregnancy rates at time of pregnancy confirmation. The number of heifers that 
experienced pregnancy loss (n = 41) was similar between treatments (15.5 vs. 25%) for
CON and CIDR, respectively. Pregnancy rates were similar in heifers receiving quality
grade 1 embryos compared to quality grade 2 embryos (d 30: 30.5 vs. 22.2%; d 60: 23.6 




     
     
 





   
   
   
     
   
  
    
 
  
blastocyst, 6 = blastocyst, and 7 = late blastocyst) of transferred embryos, regardless of 
quality score, there were no differences in pregnancy rates (d 30: 7.1 (n = 14), 31.8 (n = 
192), 22.3 (n = 121), and 29.5% (n = 112); d 60: 8.3 (n = 12), 21.9 (n = 169), 17.9 (n = 
106), and 25% (n = 104), respectively). Similarly, heifer BCS, age, and concentrations of 
progesterone at either sampling had no significant effect on pregnancy outcome at either
diagnosis, or confirmation.
Concentrations of progesterone
Concentrations of progesterone in serum were similar between treatment groups on d 7 
(𝑃 = 0.8690). As expected, heifers receiving the control treatment had lesser (𝑃 = 
0.0545) circulating concentrations of progesterone at d 19 compared to heifers in the 
CIDR group (3.64 ± 0.27 vs. 4.38 ± 0.27 ng/mL). As expected, heifers that were
pregnant on d 30 had increased (𝑃 < 0.0001) concentrations of progesterone on d 19 
independent of treatment group when compared to non-pregnant animals (5.21 ± 0.32 vs. 
2.81 ± 0.20 ng/mL).  Although there was a significant effect of days post-estrus (DPE)
and transfer group, there was also a significant interaction of DPE ×group on 
concentrations of progesterone at the time of embryo transfer (d 7; Table 4). There were
significant interactions for treatment × d 30 pregnancy rates (Table 2) and group × d 30 
pregnancy rates (Table 3) on concentrations of progesterone on d 19. Concentrations of 
progesterone at either d 7 and d 19 were unaffected by heifer age, BCS, embryo stage of 



















The overall pregnancy rates observed in this study are similar to some previously
reported (28.3%; Vieira et al., 2014; 27.7%; Block et al., 2010; 26.7%; de Sousa et al., 
2017), but less than others using beef or dairy cow recipients (45%; Thompson et al., 
1998; 45%; Kruip et al., 1997; 36%; Pontes et al., 2010), and even with IVP embryos 
fertilized with sex-sorted sperm (40.9%; Xu et al., 2006).  Although this current project 
was not designed to assess pregnancy loss, others have found pregnancy loss in IVP 
embryo recipients to be caused by failure of placental membrane development and a
reduced placental blood vessel development (Farin et al., 2006).  Despite the pregnancy
rates observed, Hasler, (2014) found heifer recipients to have 10 to 23% greater
pregnancy rates compared to cows, in general.  Similar pregnancy rates were observed 
for all stages of embryonic development of embryos transferred in this study. However, 
Hasler (2012) found that embryos of a developmental stage 7 had decreased survival 
post-transfer when compared to both stage 5 and 6 embryos post-transfer (43.8 vs. 55.3 
vs. 52.1%, respectively). In the current study, there was an observed effect of transfer 
group on pregnancy rates at d 30, where embryos transferred into recipients in March had 
the lowest pregnancy rates compared to transfer groups in December, January, February, 
and April.  Lussier et al., (1987) observed that an interval of 40 to 50 days, equivocal to 2 
estrous cycles, is required to grow follicles through the antral stage (0.13 mm) to the
preovulatory size, indicating the oocyte and follicular cells in the Graafian follicle may be
affected by adverse effects for an extended period of time prior to ovulation.  Heat stress 
negatively impacted oocyte quality and increased the abundance of degenerate theca and 




   





   
 









quality. Pregnancy rates for both quality grades of embryos in this study did not differ, 
but previous studies have found that embryos assigned a quality grade 1 had 5- 10%
higher pregnancy rates compared with those assigned to a quality grade 2 (Vieira et al., 
2014; Ferraz et al., 2016). BCS of heifers did not alter pregnancy outcomes in this study.  
However, Ambrose et al., (1999) projected pregnancy rates of lactating Holstein cow ET 
recipients to increase by 37% for each whole unit increase in BCS.  
Concentrations of progesterone at cessation of treatment for all pregnant animals, 
and pregnant animals that received a CIDR device, were similar to those found 
previously (Pandey et al., 2016). Previously, BCS has been positively associated with 
plasma concentrations of progesterone: with every whole unit increase of BCS in 
lactating Holstein ET recipients, Ambrose et al., (1999) projected an increase in 
circulating progesterone of 2.9 ng/mL. In vitro fertilization rates and blastocyst 
development (Palma et al., 2008; Mikkola et al., 2017), and even pregnancy rates 
(Tonello et al., 2005) can vary between bulls.  However, due to the number of bulls used 
in this study, the treatment × sire interaction on pregnancy rates observed in this study
may be of limited biological value.  Palma et al., (2008) found IVP embryos fertilized 
with sex-sorted sperm have ultrastructural differences compared to those fertilized with 
non-sexed sperm.  Despite these differences, Rasmussen et al., (2012) did not report a
difference in pregnancy rates at either d 32 or d 60 of gestation between lactating cow 
recipients receiving IVP embryos produced from sex-sorted sperm compared to IVP 
embryos fertilized from non-sorted sperm cells (d 32: 28 vs. 24%; d 60: 18 vs. 21%, 
respectively). Though this study explicitly dealt with frozen-thawed IVP embryos, the




    
  

















vivo derived embryos (Ambrose et al., 1999; Block et al., 2010; Do et al., 2016).
Pregnancy rates are influenced by donor-recipient synchrony, and embryo developmental 
stage and quality grade (Hasler et al., 2001), but no such effects were found in the present 
study. Heifer pregnancy rates were unaffected by days post-estrus of the recipient at 
embryo transfer, however it has been reported previously that animals that are only 6 
days post-estrus at time of transfer are less likely to establish a pregnancy than those 7 
and 8 days post-estrus (38.4 vs. 44.3 vs. 43%; Ferraz et al., 2016).
In conclusion, supplemental progesterone via a CIDR device did increase
circulating progesterone concentrations, but had no effect on pregnancy rates of dairy
heifers that received an IVP embryo.  Further research is vital in this field of study to 
improve IVP embryonic survivability and pregnancy outcomes.  
Acknowledgments 
The authors would like to thank Dr. Jeremy Block for assistance with the
experimental design and logistics.  Special thanks is extended to the owners and 
employees of Lewis Family Dairy for allowing this research to be conducted, and for the
use of their ET recipients.  The authors also wish to acknowledge Dr. Vitor Mercadante 
and Nicholas Wege Dias for their assistance with bloodwork analysis, and Zoetis Animal 







      
 
 





















          
 
  











Table 1 Pregnancy rates among transfer groups at pregnancy diagnosis
Transfer Group
1 2 3 4 5 6 7 8 9
D 30 33.96bc 25.5abc 31.0abc 28.6abc 44c 25.8abc 16.7ab 12.5a 35.1bc
PR (18/53) (13/51) (26/84) (12/42) (11/25) (17/66) (7/42) (5/40) (13/37)
(%)
SEM 0.48 0.44 0.47 0.46 0.51 0.44 0.38 0.33 0.48
Pregnancy rates for each transfer group at pregnancy diagnosis (d 30) recorded as a
percentage of heifers pregnant from the total number of recipients used within each 
group.  Standard errors for each mean are presented.  Lack of a common superscript 












   
   
   
 
 
   
   












Table 2 Concentrations of progesterone on d 19 between treatments and pregnancy
status
D 19 P4 Concentrations 
TRT (ng/mL)
Pregnant Open
CIDR 5.19 ± 0.45c 3.57 ± 0.29b 
CON 5.23 ± 0.46c 2.04 ± 0.28a 
Concentrations of serum progesterone, in ng per mL of blood according to treatment 
group and pregnancy status on d 19. Standard errors for each mean are presented. Lack 












   
   
   
   
 
   
 











Table 3 Concentrations of progesterone on d 19 for each group based on pregnancy
status at pregnancy diagnosis
D 19 P4 Concentrations 
Group (ng/mL)
Pregnant Open
1 4.09 ± 0.54b 1.87 ± 0.39a 
2 5.5 ± 0.56c 4.02 ± 0.35b
3 6.03 ± 0.62c 2.46 ± 0.33a 
Concentrations of progesterone, in ng per mL of blood at cessation of treatment (d 19)
from the subset of heifers subjected to blood sampling in transfer group 1 (12/03/16), 
group 2 (1/08/2017) and group 3 (2/18/2017). Standard errors for each mean are














             
   
   
   
 
   
 









Table 4 Table 4 Concentrations of progesterone on d 7 among heifers differing in 
days post-estrus among groups
D 7 P4 Concentrations 
Group (ng/mL)
Days Post Estrus (DPE)
7 8
1 4.17 ± 0.26b 5.84 ± 0.42c 
2 4.28 ± 0.25
b 
4.38 ± 0.33b 
3 2.68 ± 0.19a 3.44 ± 1.51abc 
Concentrations of progesterone, in ng per mL of blood at time of embryo transfer (d 7)
between varying levels of donor-recipient synchrony from the subset of heifers subjected 
to blood sampling in transfer group 1 (12/03/16), group 2 (1/08/2017) and group 3 
(2/18/17). Standard errors for each mean are presented. Lack of a common superscript 




















Figure 1 Pregnancy rates between treatment groups at pregnancy diagnosis (d 30) and 
confirmation (d 60)
Pregnancy rate of recipients in either treatment group at pregnancy diagnosis (d 30) and
pregnancy confirmation (d 60) reported as the percentage of animals pregnant at each 
examination point amongst the total number of recipients used.  Lack of a common 







      



















Ambrose J.D., M. Drost, R.L. Monson, J.J. Rutledge, M.L. Leibfried-Rutledge, M.J. 
Thatcher, T. Kassa, M. Binelli, P.J. Hansen, P.J. Chenoweth, and W.W. Thatcher. 
1999. Efficacy of timed embryo transfer with fresh and frozen in vitro produced 
embryos to increase pregnancy rates in heat-stressed dairy cattle. J. Dairy Sci. 
82(11):2369-2376.
Block J., L. Bonilla, and P.J. Hansen. 2010. Efficacy of in vitro embryo transfer in 
lactating dairy cows using fresh or vitrified embryos produced in a novel embryo 
culture medium1. J. Dairy Sci. 93(11):5234-5242.
Blondin P. 2017. Logistics of large scale commercial IVP embryo production. Reprod.
Fert. Dev. 29:32-36.
Do V.H., S. Walton, S. Catt, and A.W. Taylor-Robinson. 2016. Requirements for
cryopreservation of in vitro-produced bovine embryos by a standard method of 
vitrification. J. Vet. Sci. Anim. Husb. 4(1):102.
Edmonsen A.J., I.J. Lean, L.D. Weaver, T. Farver, and G. Webster. 1989. A body
condition scoring chart for Holstein dairy cows. J. Dairy Sci. 72(1):68-78.
Farin P.W., J.A. Piedrahita, and C.E. Farin. 2006. Errors in development of fetuses and 
placentas from in vitro-produced embryos. Theriogenology 65(1):178-191.
Ferraz P.A., C. Burnley, J. Karanja, A Viera-Neto, J.E.P. Santos, R.C. Chebel, and K.N. 
Galvao. 2016. Factors affecting the success of a large embryo transfer program in 
Holstein cattle in a commercial herd in the southeast region of the United States. 
Theriogenology 86(7):1834-1841.
Forde N., F. Carter, T.Fair, and M.A. Crowe. 2009. Progesterone-regulated changes in 
endometrial gene expression contribute to advanced conceptus 
development in cattle. Biol. Reprod. 81(4):784-794.
Garrett J.E., R.D. Geisert, M.T. Zavy, and G.L. Morgan. 1988b. Evidence for maternal 






























Graham J.D. and C.L. Clarke. 1997. Physiological actions of progesterone in target 
tissues. Endocrine Reviews 18(4):502-519.
Hasler J.F., W.B. Henderson, P.J. Hurtgen, Z.Q. Jin, A.D. McCauley, S.A. Mower, B. 
Neely, L.S. Shuey, J.E. Stokes, and S.A. Trimmer. 1995. Production, freezing, 
and transfer of bovine IVF embryos and subsequent calving results. 
Theriogenology 43(1):141-152.
Hasler, J.F. 2001. Factors affecting frozen and fresh embryo transfer pregnancy rates in 
cattle. Theriogenology 56(9):1401-1415.
Hasler J.F. 2012. Effects of embryo stage on pregnancy rate following direct transfer of
bovine embryos frozen in ethylene glycol. Reprod. Fertil. Dev. 24:131, Abstr.
Hasler J.F. 2014. Forty years of embryo transfer in cattle: A review focusing on the 
journal of Theriogenology, the growth of the industry in North America, and 
personal reminisces. Theriogenology 81(1):152-169.
Kerbler T.L., M.M. Buhr, L.T. Jordan, K.E. Leslie, and J.S. Walton. 1997. Relationship 
between maternal plasma progesterone concentration and interferon-tau synthesis 
by the conceptus in cattle. Theriogenology 47(3):703-714.
Kruip T.A.M., J.H.G. den Daas. 1997. In vitro produced and cloned embryos: effects on 
pregnancy, parturition, and offspring. Theriogenology 47(1):43-53.
Lamb G.C., J.S. Stevenson, D. J. Kesler, H.A Garverick, D.R. Brown, and B.E. Salfen. 
2001. Inclusion of an intravaginal progesterone insert plus GnRH and 
prostaglandin F2α for ovulation control in postpartum suckled beef cows. J. 
Anim. Sci. 79(1):2253-2259.
Lonergan P. 2011. Influence of progesterone on oocyte quality and embryo development 
in the cow. Theriogenology 76(9):1594-1601.
Lussier J.G., P. Matton, and J.J. Dufour. 1987. Growth rates of follicles in the ovary of 
the cow. Reproduction 81:301-307.
Mann G.E., and G.E. Lamming. 1999. The influence of progesterone during early
pregnancy in cattle. Reprod. Domest. Anim. 34(3-4):269-274.
Mann G.E., and G.E. Lamming. 2001. Relationship between maternal endocrine
environment, early embryo development and inhibition of the luteolytic
mechanism in cows. Reproduction 121:175-180.
Mikkola M., and J. Taponen. 2017. Quality and developmental rate of embryos produced 









   







    
 
   








Monteiro P.L.J, A.B. Nascimento, G.C.S. Pontes, G.O. Fernandes, L.F. Melo, M.C. 
Wiltbank, and R. Sartori. 2015. Progesterone supplementation after ovulation:
effects on corpus luteum function and on fertility of dairy cows subjected to AI or 
ET. Theriogenology 84(7):1215-1224.
O’Hara L., N. Forde, A.K. Kelly, and P. Lonergan. 2014. Effect of bovine blastocyst size
at embryo transfer on day 7 on conceptus length on day 14: can supplementary
progesterone rescue small embryos? Theriogenology 81(8):1123-1128.
Palma G.A., N.S. Olivier, C.H. Neumueller, and F. Sinowatz. 2008. Effects of sex-sorted 
spermatozoa on the efficiency of in vitro fertilization and ultrastructure of in vitro 
produced bovine blastocysts. Anat. Histol. Embryol. 37(1):67-73.
Pandey N. K.J., H.P. Gupta, S. Prasad, and S.K. Sheetal. 2016. Plasma progesterone
profile and conception rate following exogenous supplementation of 
gonadotropin-releasing hormone, human chorionic gonadotropin, and 
progesterone releasing intra-vaginal device in repeat-breeder crossbred cows. Vet 
World 9(6):559-562.
Pontes J.H.F., K.C.F. Silva, A.C. Basso, A.G. Rigo, C.R. Ferreira, G.M.G. Santos, B.V.
Sanches, J.P.F. Porcionato, P.H.S. Vieira, F.S. Faifer, F.A.M. Sterza, J.L. Schenk, 
and M.M. Seneda. 2010. Large-scale in vitro embryo production and pregnancy
rates from Bos taurus, Bos indicus, and indicus-taurus dairy cows using sexed 
sperm. Theriogenology 74(8):1349- 1355.
Rasmussen S., J. Block, G.E. Siedel, Z. Brink, K. McSweeney, P.W. Farin, L. Bonilla, 
and P.J. Hansen. Pregnancy rates of lactating cows after transfer of in vitro 
produced embryos using X-sorted sperm. Theriogenology 79(3):453-461.
Roth Z., A Arav, A. Bor, Y. Zeron, R.Braw-Tel, and D. Wolfenson. 2001. Improvement 
of quality of oocytes collected in the autumn by enhanced removal of impaired 
follicles from previously heat-stressed cows. Reproduction 122:737-744.
Sousa de R.V., C.R. da Silva Cardoso, G. Butzke, M.A.N. Dode, R. Rumpf, and M.M. 
Franco. 2017.Biopsy of bovine embryos produced in vivo and in vitro does not
affect pregnancy rates. Theriogenology 90:25-31.
Sreenan J.M., and M.G. Diskin. 1983. Early embryonic mortality in the cow: its 
relationship with progesterone concentrations. Vet. Rec. 112(22):517-521.
Thompson J.G., N.W. Allen, L.T. McGowan, A.C.S. Bell, M.G. Lambert, and H.R. 
Tervit. 1998. Effect of delayed supplementation of fetal calf serum to culture
























Tonello T.T.M., M.F. Accorsi, M.L. Ferraz, M.R. Watanabe, F.D.P. Meirelles, F.V. 
Meirelles, and Y.F., Watanabe. 2005. Produçao in vitro de embriões bovinos a
partir de sêmen sexado. Proceedings of the XIX Meeting of the Brazilian Society
of Embryo Technology. 26–29 August. Acta Sci. Vet. 33(Suppl. 1):350.
Ulbrich S.E., K. Zitta, S. Hiendleder, and E. Wolf. 2010. In vitro systems for intercepting
early embryo-maternal cross-talk in the bovine oviduct. Theriogenology
73(6):802-816.
VanCleeff J., K.I. Macmillan, M. Drost, M.C. Lucy, and W.W. Thatcher. 1996. Effects of 
administering progesterone at selected intervals after insemination of
synchronized heifers on pregnancy rates and resynchronization of return to 
service. Theriogenology 46(7):1117-1130.
Vieira I.M., C.A. Rodrigues, M.F. Mendanha, M.F. Sa Filho, J.N.S Sales, A.H. Souza, 
J.E.P. Santos, and P.S. Baruselli. 2014. Donor category and seasonal climate 
associated with embryo production and survival in multiple ovulation and embryo 
transfer programs in Holstein cattle. Theriogenology 82(2):204-212.
Wildman E.E., G.M. Jones, P.E. Wagner, R.L. Bowman, H.F. Troutt, and T.N. Lesch. 
1982. A dairy cow body condition scoring system and its relationship to selected 
production characteristics. J. Dairy Sci. 65(3):495-501. 
Xu J., G.L. Su, T.L. Nedambale, J. Zhang, J. Schenk, J.F. Moreno, A. Dinnyes, W. Ji, 
X.C. Tian, X. Yang, and F. Du. 2006. Developmental Potential of Vitrified 
Holstein Cattle Embryos Fertilized in Vitro with Sex-Sorted Sperm. J. Dairy Sci. 
89(7):2510-2518.
42
